David Alan Goodkin

David Alan Goodkin

Corporate Officer/Principal bei Goodkin Biopharma Consulting LLC

Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von David Alan Goodkin

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 142
16
Subsidiary Pharmaceuticals: Other 16
5
Private Company Medical Specialties 5

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von David Alan Goodkin

UnternehmenSektorVerknüpfte PersonenHauptposition
College/University

Roger Perlmutter

Bradley J. Maroni

Wen Chen

Kevin L. Stark

Luis Borges

Rachel Lenington

Corporate Officer/Principal

Doctorate Degree

Graduate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

University of California, Santa Barbara College/University

Frederick Gluck

Richard Nanula

Gary L. Wilcox

Daniel Vapnek

Warren Wayne Myers

Director/Board Member

Undergraduate Degree

Doctorate Degree

Corporate Officer/Principal

Undergraduate Degree

Harvard Business School College/University

Frank J. Biondi

Kevin Sharer

Richard Nanula

Henry Wu

Marc M. P. de Garidel

Masters Business Admin

Corporate Officer/Principal

Masters Business Admin

Masters Business Admin

Masters Business Admin

College/University

Robert S. Attiyeh

Judith C. Pelham

Kathleen M. Wiltsey

Wen Chen

Urte Gayko

Masters Business Admin

Graduate Degree

Masters Business Admin

Corporate Officer/Principal

Doctorate Degree

Miscellaneous Commercial Services

Robert S. Attiyeh

Frederick Gluck

Kevin Sharer

Andrew Gengos

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Kevin Sharer

Richard Nanula

J. Reason

James Daly

Chief Executive Officer

Director of Finance/CFO

Director/Board Member

Corporate Officer/Principal

University of California, Los Angeles College/University

Gary L. Wilcox

Kathryn Falberg

Gary Palmer

David Hovland

Corporate Officer/Principal

Undergraduate Degree

Graduate Degree

Doctorate Degree

University of British Columbia College/University

Paul Geyer

Kevin Leong

Zeid Mohamedali

Gordon Ng

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

College/University

Brian M. McNamee

Robert S. Attiyeh

Richard Yeh

Mark Daniels

Graduate Degree

Undergraduate Degree

Masters Business Admin

Undergraduate Degree

BIOGEN INC. Pharmaceuticals: Major

Carol Gallagher

John F. Weidenbruch

Kevin Koch

David Hallal

Sales & Marketing

General Counsel

President

Sales & Marketing

Pepperdine University College/University

Wen-Tse Tseng

Warren Wayne Myers

Michael A. Grabow

Rachel Lenington

Masters Business Admin

Graduate Degree

Masters Business Admin

Masters Business Admin

MERCK & CO., INC. Pharmaceuticals: Major

George Morrow

Roger Perlmutter

Beth Seidenberg

Sandra Milligan

Sales & Marketing

Chief Tech/Sci/R&D Officer

Private Equity Investor

Chief Tech/Sci/R&D Officer

Colorado State University College/University

John G. Adair

Randal A. Hassler

Kevin L. Stark

Undergraduate Degree

Graduate Degree

Undergraduate Degree

ELI LILLY AND COMPANY Pharmaceuticals: Major

Carol Gallagher

Lisa Guttman

Marc M. P. de Garidel

Sales & Marketing

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Carol Gallagher

Kevin Koch

Lisa A. Evrén

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Martin Simonetti

Aron M. Knickerbocker

Sandra Milligan

Comptroller/Controller/Auditor

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Brian M. McNamee

Kevin Sharer

Sean E. Harper

Director/Board Member

Chairman

Chief Executive Officer

UNITY BIOTECHNOLOGY, INC. Biotechnology

John Smither

David Lacey

Susan Lundeen Smuck

Director of Finance/CFO

Director/Board Member

Human Resources Officer

College/University

George Morrow

Bradford Zakes

Ann Miller

Masters Business Admin

Masters Business Admin

Undergraduate Degree

ACELYRIN, INC. Pharmaceuticals: Major

Beth Seidenberg

Sean E. Harper

Patricia A. Turney

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Roger Perlmutter

Beth Seidenberg

Sean E. Harper

President

Corporate Officer/Principal

Corporate Officer/Principal

ARCUS BIOSCIENCES, INC. Biotechnology

Kathryn Falberg

Juan Jaen

David Lacey

Director/Board Member

Founder

Director/Board Member

University of Kansas College/University

Philip C. Ranker

Daniel Flynn

Sesha Neervannan

Undergraduate Degree

Doctorate Degree

Doctorate Degree

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Beth Seidenberg

Timothy McNamara

Aron M. Knickerbocker

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Hallal

Eric Grinstead

John Moriarty

Chief Executive Officer

General Counsel

General Counsel

New York University College/University

Maureen P. Brogan

Frederick Gluck

Lisa A. Evrén

Undergraduate Degree

Graduate Degree

Graduate Degree

University of California, Berkeley College/University

William D. Welch

Sean E. Harper

David Hovland

Doctorate Degree

Doctorate Degree

Undergraduate Degree

College/University

David Baltimore

Kevin Sharer

Kathleen M. Wiltsey

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

David Baltimore

Andrew Gengos

Henry R. Appelbaum

Corporate Officer/Principal

Undergraduate Degree

Graduate Degree

MIRATI THERAPEUTICS Biotechnology

Carol Gallagher

John Moriarty

Director/Board Member

General Counsel

KYTHERA BIOPHARMACEUTICALS INC Pharmaceuticals: Major

John Smither

Susan Lundeen Smuck

Director of Finance/CFO

Human Resources Officer

RAPT THERAPEUTICS, INC. Pharmaceuticals: Major

Beth Seidenberg

Juan Jaen

Director/Board Member

President

Investment Managers

Paul Clark

Bradford Zakes

Director/Board Member

Chief Executive Officer

ATARA BIOTHERAPEUTICS, INC. Pharmaceuticals: Major

Beth Seidenberg

Carol Gallagher

Director/Board Member

Chairman

CATALENT, INC. Pharmaceuticals: Major

Paul Clark

Madhavan Balachandran

Director/Board Member

Director/Board Member

FIVE PRIME THERAPEUTICS, INC. Biotechnology

Aron M. Knickerbocker

Luis Borges

Chief Executive Officer

Chief Tech/Sci/R&D Officer

EPIZYME, INC. Biotechnology

Beth Seidenberg

John F. Weidenbruch

Director/Board Member

General Counsel

BIOCRYST PHARMACEUTICALS, INC. Biotechnology

Beth Seidenberg

William P. Sheridan

Director/Board Member

Corporate Officer/Principal

Pharmaceuticals: Major

Gary L. Wilcox

Madhavan Balachandran

Founder

Chief Executive Officer

NGM BIOPHARMACEUTICALS, INC. Biotechnology

Roger Perlmutter

Alex M. DePaoli

Director/Board Member

Chief Tech/Sci/R&D Officer

ASPIRA WOMEN'S HEALTH INC. Biotechnology

Daniel Vapnek

Sandra Milligan

Director/Board Member

President

Investment Managers

Roger Perlmutter

David Baltimore

Corporate Officer/Principal

Corporate Officer/Principal

IMMUNE DESIGN CORP Pharmaceuticals: Major

Roger Perlmutter

David Baltimore

Director/Board Member

Founder

Pharmaceuticals: Major

Frederick Gluck

Gary L. Wilcox

Founder

Director/Board Member

Washington University in St. Louis College/University

Roger Perlmutter

Aron M. Knickerbocker

Doctorate Degree

Undergraduate Degree

STEVANATO GROUP S.P.A. Medical Specialties

Fabrizio Bonanni

Madhavan Balachandran

Director/Board Member

Director/Board Member

BB BIOTECH AG Financial Conglomerates

David Baltimore

Laura Hamill

Director/Board Member

Director/Board Member

Statistik

International

Vereinigte Staaten 48
Kanada 2
Italien 2
Schweiz 2

Sektoral

Health Technology 30
Consumer Services 16
Finance 6
Commercial Services 2

Operativ

Director/Board Member 470
Corporate Officer/Principal 255
Independent Dir/Board Member 139
Chairman 91
Undergraduate Degree 88
  1. Börse
  2. Insiders
  3. David Alan Goodkin
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT